Braveheart announces that on 18 November 2020, it sold a total of 112,592,405 ordinary shares in Remote Monitored System plc (“RMS”).
Braveheart Inv Group (BRH.L) Share transactions in Remote Monitored Systems plc
TPI provides its latest research note on DeepVerge plc (DVRG.L).
As part of the extended field trial for DeepVerge’s Microtox PD unit, its COVID-19 enabled near-source wastewater contamination test system, deployment into a number ofIrish water treatment plants has now
Yoav Keren, CEO at BrandShield & John Taylor, NED Two Shields Investments (TSI.L) Interview
Restoration – Two Shields Investments plc Trading on AIM for the under-mentioned securities was temporarily suspended. The suspension is lifted from 11/11/2020 7:30am, an announcement having been made and admission
MelodyVR Group PLC (MVR.L) Global exclusive with Liam Gallagher
MelodyVR unveils a global exclusive with Liam Gallagher as the latest in its acclaimed concert series with Live Nation
Mirriad Advertising (MIRI.L) launches music alliance
Seamless brand integrations in music content to create new revenue opportunities for artists
Q-AI Limited (IQAI.L) IB and the Mayo Clinic enter into an Agreement
IB and the Mayo Clinic Enter into an Agreement to Develop IB Trax™
Chris Jeffries, CEO Dev Clever (DEV.L) Interview
Heads of Terms AgreementStrategic partnership and formation of B2C model in India
Dev Clever Holdings (DEV.L) Heads of Terms Agreement
Heads of Terms AgreementStrategic partnership and formation of B2C model in India
IQ-AI Limited (IQAI.L) Montgomery Cancer Center Purchases IB’s Software
Imaging Biometrics®, LLC (“IB”), a subsidiary of IQ-AI Limited (LON:IQAI), is pleased to announce that the Montgomery Cancer Center (Montgomery, Alabama, USA), has purchased IB Clinic.
Ben Crawford, Chief Executive Officer of CentralNic PLC (CNIC.L) Interview
Completion of Acquisition of Zeropark and Voluum
Sensyne Health PLC (SENS.L) COVID-19 testing study at University of Oxford
Sensyne Health’s CVm-Health+ ä software application to facilitate rapid COVID-19 antigen testing study by the University of Oxford
